Good Results For Merck Cholesterol Drug
562923
Merck will have a strong sales pitch for Cordaptive, even if it doesn't convince the skeptics.
409638
Promising trials for a hepatitis C treatment bode well for the pharmaceutical.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
707960
German drugs and chemicals group Merck&#39;s third-quarter operating profit rose by a forecast-beating 42 percent, helped by strong sales of cancer drug Erbitux and liquid crystals for flat screen televisions.
395860
Blueberries, already the darlings of the fruit world for their potential disease-fighting ability, may have yet another compound to help lower cholesterol. A compound called pterostilbene performed better, at least in a lab study with rats, than a common cholesterol-lowering drug.
633683
Merck & Co&#39;s   combination pill to raise &quot;good&quot; HDL cholesterol with less  facial flushing -- a common side effect of HDL drugs -- met its  main goals in a late-stage test, researchers said on Sunday.
493018
Aug 25  - An antioxidant found in blueberries and grapes appears to lower cholesterol as effectively as a commercial drug, according to preliminary study findings released Monday.
411818
A drug combination that produced such positive results in clinical trials that they were stopped before their scheduled completion date reduces death from coronary heart disease by up to 43 percent, a new study reports.
448598
Drugs to raise so-called good cholesterol may still have a future despite the widely publicized failure last year of an experimental cholesterol treatment from Pfizer, researchers said.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
451536
The fruits contain a compound that works similarly to a drug used to reduce levels of harmful cholesterol, according to tests on rat liver cells.
731127
Merck said on Wednesday that short-term studies had shown its planned successor, Arcoxia, to be safer.
208543
Vioxx was already a big success as an arthritis pain reliever, but Merck &amp; Co. thought it could be an even bigger seller. The drug seemed to have some cancer-prevention qualities
468910
Biomira reports favorable Phase II test results.
121268
EPIX initiates a safety trial and gets good efficacy data.
707009
An investigator hired by the companyÂs board found that Merck took Âreasonable stepsÂ to research the drugÂs health risks.
584007
Investors reward the drugmaker for positive study results.